Sunday, October 24, 2010

Primed for Picking: CEPH

Cephalon's Inc. (CEPH) stock price has shown a consistent improvement over the past six weeks, in addition, it has formed a solid base spanning three months at the 55 level.

Cephalon, Inc., is a biopharmaceutical company, which engages in the discovery, development, and commercialization of products for central nervous system, inflammatory disease, pain, and oncology therapeutic areas.

Positives are:

•Good chart pattern.
•Consistent uptrend and rebound from the lows of late August '10.
•Excellent average daily volume of about 1.2 million shares.
•Increased fund interest since June '10.
•Forward P/E ratio is at about 9.

Trading at 64.10, CEPH seems to be a good prospect.

No comments:

Post a Comment